![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | |
A61K 49/00 | |||
A61K 35/17 | |||
C07K 16/28 | |||
C07K 16/32 | |||
C07K 14/735 | |||
G01N 33/50 | |||
A61K 35/12 | |||
C12N 5/0783 |
(11) | Number of the document | 2801583 |
(13) | Kind of document | T |
(96) | European patent application number | 14171739.7 |
Date of filing the European patent application | 2005-07-08 | |
(97) | Date of publication of the European application | 2014-11-12 |
(45) | Date of publication and mention of the grant of the patent | 2018-04-25 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
586581 P | 2004-07-10 | US |
(72) |
Campbell, Kerry S., US
|
(73) |
Fox Chase Cancer Center,
333 Cottman Avenue, Philadelphia, PA 19111-2497,
US
|
(54) | Genetically modified human natural killer cell lines |
Genetically modified human natural killer cell lines |